Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
NEW ORLEANS , June 27, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securitie
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investo
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors wh
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Hims & He
HIMZ: Buy For Short-Term Gains On Hims & Hers Health, But Be Wary Of The Risks
11:39am, Friday, 27'th Jun 2025
HIMZ offers 2x leveraged exposure to HIMS, ideal for high-risk, short-term traders seeking amplified volatility, not long-term investors. Recent HIMS volatility, including the Novo Nordisk partnership
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
10:00am, Friday, 27'th Jun 2025
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are
Class Action Announcement for Hims & Hers Health, Inc. (HIMS): Kessler Topaz Meltzer & Check, LLP
09:43am, Friday, 27'th Jun 2025
RADNOR, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United S
Health & Fitness Stocks to Buy as the Wellness Trend Grows
09:01am, Friday, 27'th Jun 2025
SFM, BODI, and HIMS are capitalizing on the booming wellness market with digital tools, nutrition, and holistic health solutions.
SAN FRANCISCO , June 27, 2025 /PRNewswire/ -- On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company's executives.
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Hims business and prospects, resulting in its stock trading at inflated prices.
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
04:53am, Friday, 27'th Jun 2025
Up-and-coming telehealth company Hims & Hers Health (HIMS 11.98%) has capitalized on the weight loss drug craze to become one of the market's top performers over the past few years.
Massive News for Hims & Hers Stock Investors!
04:02am, Friday, 27'th Jun 2025
Hims & Hers' (HIMS 11.98%) stock crashed over 30% following news highlighting the end of its relationship with Novo Nordisk (NVO 0.63%).
Down Over 30%, What's Going on With Hims & Hers stock?
03:33am, Friday, 27'th Jun 2025
This growth stock experienced a significant decline in stock price following an announcement with a key partner.
OAKLAND, Calif.--(BUSINESS WIRE)---- $HIMS #ClassAction--Gibbs Mura announces a class action lawsuit has been filed on behalf of Hims & Hers Health, Inc. investors.
